St. Louis Trust Co Sells 2,319 Shares of Colgate-Palmolive (NYSE:CL)

St. Louis Trust Co lowered its stake in shares of Colgate-Palmolive (NYSE:CL) by 31.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,100 shares of the company’s stock after selling 2,319 shares during the period. St. Louis Trust Co’s holdings in Colgate-Palmolive were worth $529,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of CL. Baron Wealth Management LLC purchased a new position in Colgate-Palmolive during the 3rd quarter valued at approximately $245,000. OneAscent Wealth Management LLC purchased a new position in shares of Colgate-Palmolive in the third quarter valued at $371,000. Meeder Advisory Services Inc. increased its position in Colgate-Palmolive by 1.2% in the third quarter. Meeder Advisory Services Inc. now owns 18,795 shares of the company’s stock worth $1,951,000 after purchasing an additional 226 shares during the last quarter. Drive Wealth Management LLC raised its stake in Colgate-Palmolive by 9.5% during the third quarter. Drive Wealth Management LLC now owns 2,432 shares of the company’s stock valued at $252,000 after purchasing an additional 211 shares in the last quarter. Finally, Capital City Trust Co. FL lifted its position in Colgate-Palmolive by 0.8% during the third quarter. Capital City Trust Co. FL now owns 59,430 shares of the company’s stock valued at $6,169,000 after purchasing an additional 483 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The trade was a 16.44 % decrease in their position. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by insiders.

Colgate-Palmolive Trading Up 1.2 %

NYSE CL opened at $94.65 on Tuesday. Colgate-Palmolive has a one year low of $75.17 and a one year high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The company has a market capitalization of $77.33 billion, a price-to-earnings ratio of 27.12, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. The company’s 50-day simple moving average is $99.06 and its two-hundred day simple moving average is $98.55.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their target price for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Piper Sandler assumed coverage on Colgate-Palmolive in a research report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price objective on the stock. Morgan Stanley raised their price objective on Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. UBS Group increased their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Finally, HSBC restated a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $105.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.